Calling this number connects you with an elite member of the Weitz & Luxenberg legal team, who will conduct a free case review and provide you with more information about your legal options. Members of our experienced team are on call 24/7 to answer your questions and ensure that all your needs are met.
Your first generation Smith & Nephew Journey Bi-cruciate Stabilized (BCS) Knee replacement system (Journey I BCS Knee System) may be defective. The manufacturer issued a voluntary recall in June of 2018, but phased this model out of production five years ago. If you had a first generation Smith & Nephew Journey BCS knee implanted, and the product failed, you may be entitled to compensation.
Weitz & Luxenberg is currently accepting clients who received a first generation Smith & Nephew Journey BCS knee and subsequently needed to undergo a revision, or replacement, surgery or have been advised by their doctor they need to undergo a revision surgery due to femoral component loosening. We invite you to contact us for more information about your legal options.
If you have undergone a knee replacement surgery, are having problems, and are not sure whether you received a first generation Smith & Nephew Journey BCS knee, we encourage you to ask your doctor which knee replacement model you received. Depending on your specific implant, you may be able to seek compensation.
First Generation Journey BCS Knee Complications
Revision surgeries are costly. You may also need to undergo follow-up treatment and physical therapy.
You may not be able to earn a living if your knee complications keep you disabled at home. Your total medical costs could become exorbitant.
Possible first generation Smith & Nephew Journey BCS knee implant complications for which you could receive compensation may include:
Recommendation from your physician to undergo a revision surgery due to femoral component loosening.
Revision surgery due to femoral component loosening.
Knee Implant Recall
Smith & Nephew voluntarily recalled its first generation Journey BCS Knee System on June 13, 2018. The U.S. Food and Drug Administration later categorized this recall as Class 2. (1) (2)
For a free consultation and more information about your legal options, please contact us today.
The manufacturer indicated in its Urgent Field Safety Notice that this knee was failing as a higher rate than other primary total knee arthroplasty implants. It noted that data in two joint registries “indicate that the first generation JOURNEY BCS Knee System has a revision rate over 1.5 times the primary total knee arthroplasty device class average revision rates reported in those registries.” (3) (4) (5)
In its Urgent Field Safety Notice Smith & Nephew asked customers to inspect inventory and locate and quarantine affected, unused devices. (6) (7) (8)
Field Safety Notice
In its Urgent Field Safety Notice, Smith & Nephew said the affected product was its first-generation Journey BCS, which was introduced to the market in 2005. The company phased this model out of production between 2013 and 2014. (9) (10)
Smith & Nephew said its “analysis of available post-market surveillance data suggests that patients that have been implanted with a first generation JOURNEY BCS Knee System may have a higher risk of requiring a revision earlier than they or their surgeon had expected.” (11) (12)
On July 23, 2018, the United Kingdom issued a medical device alert instructing against implanting Smith & Nephew’s first generation Journey BCS knee device and cautioned physicians to monitor patients regularly for up to 10 years for signs of device loosening. (13) (14)
In addition, the U.K.’s medical device alert notes the National Joint Registry of England, Wales, and Northern Ireland showed the revision rate for this knee device was more than double the average rate for primary total knee replacements. (15) (16)
What Studies Show
According to authors of one study partially funded by Smith & Nephew, Smith & Nephew’s first generation Journey BCS had a significantly higher rate of revision than Smith & Nephew’s Journey II knee. The Journey I had a risk of revision over four times higher than the Journey II. (17) (18)
Hear From Our Clients
"I chose Weitz & Luxenberg because the firm has a reputation for working really hard. I went with them because I didn’t want just anybody representing me. I felt that, if I was going to sue, I wanted a firm that had a lot of experience and a lot of resources. I wanted the big guns."
Weitz & Luxenberg has been litigating cases involving defective medical devices for decades. As a national firm, we are prepared to handle large-scale medical device litigation across the country.
Our attorneys make it their mission to help clients harmed by defective medical products any medical device corporations create and promote. They are specially trained to handle complex medical device lawsuits.
If you were implanted with a defective knee replacement, we may be able to seek appropriate compensation on your behalf. Over the years, we have secured millions of dollars on behalf of clients injured by faulty medical devices.
For more information, we encourage you to contact us at (800) 476-6070.
Christen, B., & Kopjar, B. (2018, August 25). Second-generation bi-cruciate stabilized total knee system has a lower reoperation and revision rate than its predecessor. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30167859